PRIMECAP MANAGEMENT CO/CA/ 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 6:24 pm Sale | 2024-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 4,616,130 4.580% | -5,295,101 (-53.43%) | Filing |
| 2024-11-12 4:01 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 9,911,231 9.870% | -4,560,697 (-31.51%) | Filing |
| 2024-02-12 4:01 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 14,471,928 14.720% | 576,850 (+4.15%) | Filing |
| 2023-02-09 4:01 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 13,895,078 14.790% | 905,955 (+6.97%) | Filing |
| 2022-02-10 12:23 pm Purchase | 2021-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 12,989,123 14.010% | 3,761,103 (+40.76%) | Filing |
| 2021-01-07 10:04 am Purchase | 2009-02-28 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 9,228,020 10.140% | 4,205,487 (+83.73%) | Filing |
| 2020-04-24 3:53 pm Purchase | 2009-02-28 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 5,022,533 5.710% | 5,022,533 (New Position) | Filing |